5-chloro-4-{[5-chloro-6-(2,2,3,3-tetrafluoropropoxy)pyridin-3-yl]oxy}-N-[(dimethylamino)sulfonyl]-2-fluorobenzamide | 1446444-96-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 5-chloro-4-{[5-chloro-6-(2,2,3,3-tetrafluoropropoxy)pyridin-3-yl]oxy}-N-[(dimethylamino)sulfonyl]-2-fluorobenzamide
• 英文别名: 5-chloro-4-(5-chloro-6-(2,2,3,3-tetrafluoropropoxy)pyridin-3-yloxy)-N-(N,N-dimethylsulfamoyl)-2-fluorobenzamide；US10071957, Example 30；5-chloro-4-[5-chloro-6-(2,2,3,3-tetrafluoropropoxy)pyridin-3-yl]oxy-N-(dimethylsulfamoyl)-2-fluorobenzamide
• CAS: 1446444-96-7
• 化学式: C₁₇H₁₄Cl₂F₅N₃O₅S
• 分子量: 538.279
• InChiKey: UOURQUTWYWICIZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  33
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  106
• 氢给体数：
  1
• 氢受体数：
  12

文献信息

• N-SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF
  申请人：GENENTECH, INC.

  公开号：US20150322002A1

  公开（公告）日：2015-11-12

  The invention provides novel compounds having the general formula (I) and pharmaceutically acceptable salts thereof, wherein the variables RA, subscript n, ring A, X 2 , L, subscript m, X 1 , ring D, R 1 , and R N have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.

  本发明提供了具有一般式(I)及其药学上可接受的盐的新化合物，其中变量RA、下标n、环A、X2、L、下标m、X1、环D、R1和RN的含义如本文所述，并且包含这种化合物的组合物以及使用这种化合物和组合物的方法。
• N-Aminosulfonyl Benzamides
  申请人：Pfizer Limited

  公开号：US20150291514A1

  公开（公告）日：2015-10-15

  The present invention relates to sulfonamide derivatives of formula (I): or a pharmaceutically acceptable salts thereof, wherein Z, R 1a , R 1b , R 2 , R 3 , R 4 and R 5 are as defined in the description, and to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. The compounds of formula (I) are Nav1.7 inhibitors useful in the treatment of a wide range of disorders, particularly pain.

  本发明涉及公式（I）的磺酰胺衍生物或其药学上可接受的盐，其中Z，R1a，R1b，R2，R3，R4和R5如描述中所定义，并且涉及它们在医学上的应用，包含它们的组合物，用于它们的制备的过程以及用于这种过程的中间体。公式（I）化合物是Nav1.7抑制剂，可用于治疗各种疾病，特别是疼痛。
• N-substituted benzamides and methods of use thereof
  申请人：GENENTECH, INC.

  公开号：US10071957B2

  公开（公告）日：2018-09-11

  The invention provides novel compounds having the general formula (I) and pharmaceutically acceptable salts thereof, wherein the variables RA, subscript n, ring A, X2, L, subscript m, X1, ring D, R1, and RN have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.

  本发明提供了具有通式 (I) 的新型化合物及其药学上可接受的盐类，其中变量 RA、下标 n、环 A、X2、L、下标 m、X1、环 D、R1 和 RN 的含义如本文所述，本发明还提供了含有此类化合物的组合物以及使用此类化合物和组合物的方法。
• [EN] N-SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF<br/>[FR] BENZAMIDES N-SUBSTITUÉS ET LEURS PROCÉDÉS D'UTILISATION
  申请人：GENENTECH INC

  公开号：WO2014008458A2

  公开（公告）日：2014-01-09

  The invention provides novel compounds having the general formula: [insert formula (I)] and pharmaceutically acceptable salts thereof, wherein the variables RA, subscript n, ring A, X2, L, subscript m, X1, ring D, R1, and RN have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.